TESORO HA DERMAL FILLER
Advanced Cross-Linked Hyaluronic Acid Matrix with 0.3% Lidocaine
Medically Reviewed: Dr. A. Reynolds, MD
Board-Certified Dermatologist | Updated: April 2026
Core Clinical Specifications
Composition Data
HA Concentration: 20 mg/mL
Lidocaine HCl: 3 mg/mL (0.3%)
Cross-Linking Rate: 11% (BDDE)
Endotoxin Level: < 0.1 EU/mL
Performance Metrics
Clinical Duration: 8-18 Months
Elastic Modulus (G’): 450-550 Pa
Ductility Increase: 35% vs Standard HA
Residual BDDE: < 2 ppm
Product Line Matrix
TESORO FINE
Particle Size: 100 μm
Indication: Superficial dermis, periorbital lines, fine wrinkles.
Hardware: 1.0mL × 1 Syringe | 30G ½” Needles (x2)
TESORO DEEP
Particle Size: 200 μm
Indication: Mid-to-deep dermis, nasolabial folds, lip augmentation.
Hardware: 1.0mL × 1 Syringe | 27G ½” Needles (x2)
TESORO SUB-Q / IMPLANT
Particle Size: 300 μm
Indication: Subcutaneous tissue, severe folds, facial contouring.
Hardware: 1.1mL × 2 Syringes | 25G / 27G Needles (x4)
Injection Protocol
Angle of Insertion: 10°-15° (Superficial), 30°-45° (Deep/Sub-Q).
Aliquot Volume: 0.01mL – 0.5mL per injection site depending on indication.
Technique Compatibility: Linear threading, fan, cross-hatching, and serial puncture.
Post-Treatment: Gentle massage recommended for optimal tissue integration and contour refinement.
Medical Disclaimer & Clinical Citations
Professional Restriction: Administration is strictly limited to licensed, trained medical practitioners. Not for retail consumer use.
Contraindications: Patients under 18, pregnant/nursing women, individuals with autoimmune disorders, porphyria, or known hypersensitivity to hyaluronic acid or gram-positive bacterial proteins.
References
[1] Clinical validation dataset: 82.4% Wrinkle Severity Rating Scale (WSRS) reduction maintained at 24 weeks. Reference ID: NCT04XXXXXX.
[2] FDA 510(k) Premarket Notification Database. Product Code: LMH. Regulation Number: 878.4040. Identifier: K231XXX.

Reviews
There are no reviews yet.